Page 62 - Strategies for non-invasive managementof high-grade cervical intraepithelial neoplasia - prognostic biomarkers and immunotherapy Margot Maria Koeneman
P. 62
Chapter 2
56. Wentzensen N, Sherman ME, Schiffman M, Wang SS. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecologic oncology. 2009;112(2):293-9.
57. Verhoef VM, Bosgraaf RP, van Kemenade FJ, et al. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial. The lancet oncology. 2014;15(3):315-22.
58. De Strooper LM, Hesselink BA, Berkhof J, et al. Combined CADM1/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2014 Sep;23(9):1933-7.
59. Kataja V, Syrjanen K, Syrjanen S, et al. Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data. European journal of epidemiology. 1990;6(1):9-14.
60. Syrjanen K, Parkkinen S, Mantyjarvi R, et al. Human papillomavirus (HPV) type as an important determinant of the natural history of HPV infections in uterine cervix. European journal of epidemiology. 1985;1(3):180-7.
61. Syrjanen K, Mantyjarvi R, Vayrynen M, et al. Human papillomavirus (HPV) infections involved in the neoplastic process of the uterine cervix as established by prospective follow- up of 513 women for two years. European journal of gynaecological oncology. 1987;8(1):5-16.
62. Matsumoto K, Oki A, Furuta R, et al. Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study. International journal of cancer Journal international du cancer. 2011;128(12):2898-910.
63. Mirabello L, Schiffman M, Ghosh A, et al. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. International journal of cancer Journal international du cancer. 2013;132(6):1412-22.
64. Oka N, Kajita M, Nishimura R, Ohbayashi C, Sudo T. L1 gene methylation in high-risk human papillomaviruses for the prognosis of cervical intraepithelial neoplasia. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2013;23(2):235-43.
65. Sarmadi S, Izadi-mood N, Pourlashkari M, Yarandi F, Sanii S. HPV L1 capsid protein expression in squamous intraepithelial lesions of cervix uteri and its relevance to disease outcome. Archives of gynecology and obstetrics. 2012;285(3):779-84.
66. Izadi-Mood N, Sarmadi S, Eftekhar Z, Jahanteegh HA, Sanii S. Immunohistochemical expression of p16 and HPV L1 capsid proteins as predictive markers in cervical lesions. Archives of gynecology and obstetrics. 2014 Jun;289(6):1287-92.
67. Choi YS, Kang WD, Kim SM, et al. Human papillomavirus L1 capsid protein and human papillomavirus type 16 as prognostic markers in cervical intraepithelial neoplasia 1. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2010;20(2):288-93.
68. Rauber D, Mehlhorn G, Fasching PA, Beckmann MW, Ackermann S. Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions. European journal of obstetrics, gynecology, and reproductive biology. 2008;140(2):258-62.
60
